PrimeRFP SCOUT · Federal Contract Recompete Brief

75N95024P00237 — CROSS-SPECIES TRANSCRIPTIONAL CHARACTERIZATION OF RETINORECIPIENT NEURONAL POPULATIONS

CROSS-SPECIES TRANSCRIPTIONAL CHARACTERIZATION OF RETINORECIPIENT NEURONAL POPULATIONS is a federal NONE award for Department of Health and Human Services (HHS) held by CS27 LLC. Estimated value $149K ($50K obligated). Current period of performance ends Apr 15, 2027. Last award drew 3 bidders. Place of performance: SPRINGBORO OH. Related solicitation 75N95024Q01789.

$149K
Estimated Value
$50K
Obligated
Apr 15, 2027
PoP End / Expires
3
Bidders (last award)
CS27 LLC
Incumbent

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

CS27 LLC holds $148K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 3 offers. Set-aside status: NONE. Recompete timing centers on the Apr 15, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75N95024P00237
AgencyDepartment of Health and Human Services (HHS)
IncumbentCS27 LLC
CAGE9J0B3
UEIVMS4ZLFLAKH1
NAICS541690
PSCQ301
Place of performanceSPRINGBORO OH
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitation75N95024Q01789
PoP startApr 16, 2024
PoP end (current)Apr 15, 2027
Obligated$50K
Current value$149K
Potential value$149K

CROSS-SPECIES TRANSCRIPTIONAL CHARACTERIZATION OF RETINORECIPIENT NEURONAL POPULATIONS

Recompete timing

Public
Expiring in 238 days

Current PoP ends Apr 15, 2027 (238 days remaining). Agencies typically plan 12–18 months ahead — at 7.8 months out, that window is already open. The buying decision is likely already in motion.

Watch this contract — one email →

Incumbent footprint

Public record

CS27 LLC$148K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$148K · 100% of firm total
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See the recompete window for 75N95024P00237
More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open CS27 LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75N95024P00237?

75N95024P00237 (CROSS-SPECIES TRANSCRIPTIONAL CHARACTERIZATION OF RETINORECIPIENT NEURONAL POPULATIONS) is a Department of Health and Human Services (HHS) award with an estimated value of $149K, currently held by CS27 LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75N95024P00237?

CS27 LLC is the incumbent with $148K across 1 related awards in SCOUT’s public footprint. The current period of performance ends Apr 15, 2027.

When does 75N95024P00237 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 15, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N95024P00237

SCOUT Signal

August 2026

One VA health contract was 35% of civilian federal obligations in July.

Meanwhile VA's service-disabled veteran-owned contract actions fell 41.8%. The same agency, the same month, the large-vendor lane expanding while the small-business lane contracted. Figures are civilian-agency obligations through 2026-07-31; DoD FPDS for this window is labeled incomplete.

This issue is the whole civilian market. Your capture plan isn't.

Read the August 2026 issue →